Anthoula Gaigneaux
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anthoula Gaigneaux has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Bertrand De Meulder
Molecular Biology Research Unit (URBM), University of Namur - FUNDP, Namur, Belgium
5 shared publications - Eric Bareke
Department of Human Genetics, McGill University, Montreal, Canada
5 shared publications - Eric Depiereux
Facultés Universitaires Notre-Dame de la Paix, Namur, BELGIQUE
5 shared publications - Michael Pierre
Molecular Biology Research Unit (URBM), University of Namur - FUNDP, Namur, Belgium
5 shared publications - Fabrice Berger
Molecular Biology Research Unit (URBM), University of Namur - FUNDP, Namur, Belgium
4 shared publications - Benoît De Hertogh
Bioinformatics and Biostatistics Laboratory, Molecular Biology Research Unit (URBM), FUNDP University of Namur, Namur, Belgium
3 shared publications
Latest Publications
- Open Access
- 2 November 2010
- Published by Springer Nature in BMC Bioinformatics
- Vol. 11 (1) , 541
Erratum to: PathEx: A novel multi factors based datasets selector web tool
- 2 November 2010
- Published by Springer Nature in BMC Bioinformatics
- Vol. 11 (1) , 541
Open AccessErratum to: PathEx: A novel multi factors based datasets selector web tool
- Open Access
- 22 October 2010
- Published by Springer Nature in BMC Bioinformatics
- Vol. 11 (1) , 528
PathEx: a novel multi factors based datasets selector web tool
Background: Microarray experiments have become very popular in life science research. However, if such experiments are only considered independently, the possibilities for analysis and interpretation of many life science phenomena are reduced. The accumulation of publicly available data provides biomedical researchers with a valuable opportunity to either discover new phenomena or improve the interpretation and validation of other phenomena that partially understood or well known. This can only be achieved by intelligently exploiting this rich mine of information. Description: Considering that technologies like microarrays remain prohibitively expensive for researchers with limited means to order their own experimental chips, it would be beneficial to re-use previously published microarray data. For certain researchers interested in finding gene groups (requiring many replicates), there is a great need for tools to help them to select appropriate datasets for analysis. These tools may be effective, if and only if, they are able to re-use previously deposited experiments or to create new experiments not initially envisioned by the depositors. However, the generation of new experiments requires that all published microarray data be completely annotated, which is not currently the case. Thus, we propose the PathEx approach. Conclusion: This paper presents PathEx, a human-focused web solution built around a two-component system: one database component, enriched with relevant biological information (expression array, omics data, literature) from different sources, and another component comprising sophisticated web interfaces that allow users to perform complex dataset building queries on the contents integrated into the PathEx database.
- 22 October 2010
- Published by Springer Nature in BMC Bioinformatics
- Vol. 11 (1) , 528
Open AccessPathEx: a novel multi factors based datasets selector web tool
Background: Microarray experiments have become very popular in life science research. However, if such experiments are only considered independently, the possibilities for analysis and interpretation of many life science phenomena are reduced. The accumulation of publicly available data provides biomedical researchers with a valuable opportunity to either discover new phenomena or improve the interpretation and validation of other phenomena that partially understood or well known. This can only be achieved by intelligently exploiting this rich mine of information. Description: Considering that technologies like microarrays remain prohibitively expensive for researchers with limited means to order their own experimental chips, it would be beneficial to re-use previously published microarray data. For certain researchers interested in finding gene groups (requiring many replicates), there is a great need for tools to help them to select appropriate datasets for analysis. These tools may be effective, if and only if, they are able to re-use previously deposited experiments or to create new experiments not initially envisioned by the depositors. However, the generation of new experiments requires that all published microarray data be completely annotated, which is not currently the case. Thus, we propose the PathEx approach. Conclusion: This paper presents PathEx, a human-focused web solution built around a two-component system: one database component, enriched with relevant biological information (expression array, omics data, literature) from different sources, and another component comprising sophisticated web interfaces that allow users to perform complex dataset building queries on the contents integrated into the PathEx database.
- Open Access
- 13 October 2010
- Published by Springer Nature in BMC Bioinformatics
- Vol. 11 (1) , 510
Functional Analysis: Evaluation of Response Intensities - Tailoring ANOVA for Lists of Expression Subsets
Microarray data is frequently used to characterize the expression profile of a whole genome and to compare the characteristics of that genome under several conditions. Geneset analysis methods have been described previously to analyze the expression values of several genes related by known biological criteria (metabolic pathway, pathology signature, co-regulation by a common factor, etc.) at the same time and the cost of these methods allows for the use of more values to help discover the underlying biological mechanisms.
- 13 October 2010
- Published by Springer Nature in BMC Bioinformatics
- Vol. 11 (1) , 510
Open AccessFunctional Analysis: Evaluation of Response Intensities - Tailoring ANOVA for Lists of Expression Subsets
Microarray data is frequently used to characterize the expression profile of a whole genome and to compare the characteristics of that genome under several conditions. Geneset analysis methods have been described previously to analyze the expression values of several genes related by known biological criteria (metabolic pathway, pathology signature, co-regulation by a common factor, etc.) at the same time and the cost of these methods allows for the use of more values to help discover the underlying biological mechanisms.
- Open Access
- 30 April 2010
- Published by Springer Nature in BMC Cancer
- Vol. 10 (1) , 176
Meta-analysis of archived DNA microarrays identifies genes regulated by hypoxia and involved in a metastatic phenotype in cancer cells
Background: Metastasis is a major cancer-related cause of death. Recent studies have described metastasis pathways. However, the exact contribution of each pathway remains unclear. Another key feature of a tumor is the presence of hypoxic areas caused by a lack of oxygen at the center of the tumor. Hypoxia leads to the expression of pro-metastatic genes as well as the repression of anti-metastatic genes. As many Affymetrix datasets about metastasis and hypoxia are publicly available and not fully exploited, this study proposes to re-analyze these datasets to extract new information about the metastatic phenotype induced by hypoxia in different cancer cell lines.Methods: Affymetrix datasets about metastasis and/or hypoxia were downloaded from GEO and ArrayExpress. AffyProbeMiner and GCRMA packages were used for pre-processing and the Window Welchttest was used for processing. Three approaches of meta-analysis were eventually used for the selection of genes of interest.Results: Three complementary approaches were used, that eventually selected 183 genes of interest. Out of these 183 genes, 99, among which the well knownJUNB,FOSandTP63, have already been described in the literature to be involved in cancer. Moreover, 39 genes of those, such asSERPINE1andMMP7, are known to regulate metastasis. Twenty-one genes includingVEGFAandID2have also been described to be involved in the response to hypoxia. Lastly, DAVID classified those 183 genes in 24 different pathways, among which 8 are directly related to cancer while 5 others are related to proliferation and cell motility. A negative control composed of 183 random genes failed to provide such results. Interestingly, 6 pathways retrieved by DAVID with the 183 genes of interest concern pathogen recognition and phagocytosis.Conclusion: The proposed methodology was able to find genes actually known to be involved in cancer, metastasis and hypoxia and, thus, we propose that the other genes selected based on the same methodology are of prime interest in the metastatic phenotype induced by hypoxia.
- 30 April 2010
- Published by Springer Nature in BMC Cancer
- Vol. 10 (1) , 176
Open AccessMeta-analysis of archived DNA microarrays identifies genes regulated by hypoxia and involved in a metastatic phenotype in cancer cells
Background: Metastasis is a major cancer-related cause of death. Recent studies have described metastasis pathways. However, the exact contribution of each pathway remains unclear. Another key feature of a tumor is the presence of hypoxic areas caused by a lack of oxygen at the center of the tumor. Hypoxia leads to the expression of pro-metastatic genes as well as the repression of anti-metastatic genes. As many Affymetrix datasets about metastasis and hypoxia are publicly available and not fully exploited, this study proposes to re-analyze these datasets to extract new information about the metastatic phenotype induced by hypoxia in different cancer cell lines.Methods: Affymetrix datasets about metastasis and/or hypoxia were downloaded from GEO and ArrayExpress. AffyProbeMiner and GCRMA packages were used for pre-processing and the Window Welchttest was used for processing. Three approaches of meta-analysis were eventually used for the selection of genes of interest.Results: Three complementary approaches were used, that eventually selected 183 genes of interest. Out of these 183 genes, 99, among which the well knownJUNB,FOSandTP63, have already been described in the literature to be involved in cancer. Moreover, 39 genes of those, such asSERPINE1andMMP7, are known to regulate metastasis. Twenty-one genes includingVEGFAandID2have also been described to be involved in the response to hypoxia. Lastly, DAVID classified those 183 genes in 24 different pathways, among which 8 are directly related to cancer while 5 others are related to proliferation and cell motility. A negative control composed of 183 random genes failed to provide such results. Interestingly, 6 pathways retrieved by DAVID with the 183 genes of interest concern pathogen recognition and phagocytosis.Conclusion: The proposed methodology was able to find genes actually known to be involved in cancer, metastasis and hypoxia and, thus, we propose that the other genes selected based on the same methodology are of prime interest in the metastatic phenotype induced by hypoxia.
- Open Access
- 11 January 2010
- Published by Springer Nature in BMC Bioinformatics
- Vol. 11 (1) , 17
A benchmark for statistical microarray data analysis that preserves actual biological and technical variance
Background: Recent reanalysis of spike-in datasets underscored the need for new and more accurate benchmark datasets for statistical microarray analysis. We present here a fresh method using biologically-relevant data to evaluate the performance of statistical methods. Results: Our novel method ranks the probesets from a dataset composed of publicly-available biological microarray data and extracts subset matrices with precise information/noise ratios. Our method can be used to determine the capability of different methods to better estimate variance for a given number of replicates. The mean-variance and mean-fold change relationships of the matrices revealed a closer approximation of biological reality. Conclusions: Performance analysis refined the results from benchmarks published previously. We show that the Shrinkage t test (close to Limma) was the best of the methods tested, except when two replicates were examined, where the Regularized t test and the Window t test performed slightly better. Availability: The R scripts used for the analysis are available at http://urbm-cluster.urbm.fundp.ac.be/~bdemeulder/.
- 11 January 2010
- Published by Springer Nature in BMC Bioinformatics
- Vol. 11 (1) , 17
Open AccessA benchmark for statistical microarray data analysis that preserves actual biological and technical variance
Background: Recent reanalysis of spike-in datasets underscored the need for new and more accurate benchmark datasets for statistical microarray analysis. We present here a fresh method using biologically-relevant data to evaluate the performance of statistical methods. Results: Our novel method ranks the probesets from a dataset composed of publicly-available biological microarray data and extracts subset matrices with precise information/noise ratios. Our method can be used to determine the capability of different methods to better estimate variance for a given number of replicates. The mean-variance and mean-fold change relationships of the matrices revealed a closer approximation of biological reality. Conclusions: Performance analysis refined the results from benchmarks published previously. We show that the Shrinkage t test (close to Limma) was the best of the methods tested, except when two replicates were examined, where the Regularized t test and the Window t test performed slightly better. Availability: The R scripts used for the analysis are available at http://urbm-cluster.urbm.fundp.ac.be/~bdemeulder/.